COVID-19 Impact on Global Critical Care Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 127 pages | ID: C9CB27F4A244EN
QYResearch

Abstracts

This report focuses on the global Critical Care Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Critical Care Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• CSL Behring
• Grifols
• Kedrion Biopharma
• Octapharma
• Takeda
• Bayer HealthCare
• Merck
• Mitsubishi Tanabe Pharma
• REVO Biologics
• Rockwell Medical
• Thermo Fisher Scientific
• Shanghai RAAS
• China Biologic Products
• Cosmo Pharmaceuticals
• King Pharmaceuticals

Market segment by Type, the product can be split into

• Albumin
• Prothrombin Complex Concentrates
• Antithrombin Concentrates
• Factor XIII Concentrates
• Fibrinogen Concentrates

Market segment by Application, split into

• Pulmonary Embolism (PE)
• Acute Coronary Syndrome
• Atrial Fibrillation
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Critical Care Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Critical Care Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Critical Care Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Critical Care Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Critical Care Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Albumin
  1.4.3 Prothrombin Complex Concentrates
  1.4.4 Antithrombin Concentrates
  1.4.5 Factor XIII Concentrates
  1.4.6 Fibrinogen Concentrates
1.5 Market by Application
  1.5.1 Global Critical Care Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Pulmonary Embolism (PE)
  1.5.3 Acute Coronary Syndrome
  1.5.4 Atrial Fibrillation
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Critical Care Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Critical Care Therapeutics Industry
    1.6.1.1 Critical Care Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Critical Care Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Critical Care Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Critical Care Therapeutics Market Perspective (2015-2026)
2.2 Critical Care Therapeutics Growth Trends by Regions
  2.2.1 Critical Care Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Critical Care Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Critical Care Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Critical Care Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Critical Care Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Critical Care Therapeutics Players by Market Size
  3.1.1 Global Top Critical Care Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Critical Care Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Critical Care Therapeutics Market Concentration Ratio
  3.2.1 Global Critical Care Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Critical Care Therapeutics Revenue in 2019
3.3 Critical Care Therapeutics Key Players Head office and Area Served
3.4 Key Players Critical Care Therapeutics Product Solution and Service
3.5 Date of Enter into Critical Care Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Critical Care Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2021-2026)

5 CRITICAL CARE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Critical Care Therapeutics Market Size by Application (2015-2020)
5.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Critical Care Therapeutics Market Size (2015-2020)
6.2 Critical Care Therapeutics Key Players in North America (2019-2020)
6.3 North America Critical Care Therapeutics Market Size by Type (2015-2020)
6.4 North America Critical Care Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Critical Care Therapeutics Market Size (2015-2020)
7.2 Critical Care Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Critical Care Therapeutics Market Size by Type (2015-2020)
7.4 Europe Critical Care Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Critical Care Therapeutics Market Size (2015-2020)
8.2 Critical Care Therapeutics Key Players in China (2019-2020)
8.3 China Critical Care Therapeutics Market Size by Type (2015-2020)
8.4 China Critical Care Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Critical Care Therapeutics Market Size (2015-2020)
9.2 Critical Care Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Critical Care Therapeutics Market Size by Type (2015-2020)
9.4 Japan Critical Care Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Critical Care Therapeutics Market Size (2015-2020)
10.2 Critical Care Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Critical Care Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Critical Care Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Critical Care Therapeutics Market Size (2015-2020)
11.2 Critical Care Therapeutics Key Players in India (2019-2020)
11.3 India Critical Care Therapeutics Market Size by Type (2015-2020)
11.4 India Critical Care Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Critical Care Therapeutics Market Size (2015-2020)
12.2 Critical Care Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Critical Care Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Critical Care Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 CSL Behring
  13.1.1 CSL Behring Company Details
  13.1.2 CSL Behring Business Overview and Its Total Revenue
  13.1.3 CSL Behring Critical Care Therapeutics Introduction
  13.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2015-2020))
  13.1.5 CSL Behring Recent Development
13.2 Grifols
  13.2.1 Grifols Company Details
  13.2.2 Grifols Business Overview and Its Total Revenue
  13.2.3 Grifols Critical Care Therapeutics Introduction
  13.2.4 Grifols Revenue in Critical Care Therapeutics Business (2015-2020)
  13.2.5 Grifols Recent Development
13.3 Kedrion Biopharma
  13.3.1 Kedrion Biopharma Company Details
  13.3.2 Kedrion Biopharma Business Overview and Its Total Revenue
  13.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
  13.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2015-2020)
  13.3.5 Kedrion Biopharma Recent Development
13.4 Octapharma
  13.4.1 Octapharma Company Details
  13.4.2 Octapharma Business Overview and Its Total Revenue
  13.4.3 Octapharma Critical Care Therapeutics Introduction
  13.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2015-2020)
  13.4.5 Octapharma Recent Development
13.5 Takeda
  13.5.1 Takeda Company Details
  13.5.2 Takeda Business Overview and Its Total Revenue
  13.5.3 Takeda Critical Care Therapeutics Introduction
  13.5.4 Takeda Revenue in Critical Care Therapeutics Business (2015-2020)
  13.5.5 Takeda Recent Development
13.6 Bayer HealthCare
  13.6.1 Bayer HealthCare Company Details
  13.6.2 Bayer HealthCare Business Overview and Its Total Revenue
  13.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
  13.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2015-2020)
  13.6.5 Bayer HealthCare Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Critical Care Therapeutics Introduction
  13.7.4 Merck Revenue in Critical Care Therapeutics Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Mitsubishi Tanabe Pharma
  13.8.1 Mitsubishi Tanabe Pharma Company Details
  13.8.2 Mitsubishi Tanabe Pharma Business Overview and Its Total Revenue
  13.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
  13.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2015-2020)
  13.8.5 Mitsubishi Tanabe Pharma Recent Development
13.9 REVO Biologics
  13.9.1 REVO Biologics Company Details
  13.9.2 REVO Biologics Business Overview and Its Total Revenue
  13.9.3 REVO Biologics Critical Care Therapeutics Introduction
  13.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2015-2020)
  13.9.5 REVO Biologics Recent Development
13.10 Rockwell Medical
  13.10.1 Rockwell Medical Company Details
  13.10.2 Rockwell Medical Business Overview and Its Total Revenue
  13.10.3 Rockwell Medical Critical Care Therapeutics Introduction
  13.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2015-2020)
  13.10.5 Rockwell Medical Recent Development
13.11 Thermo Fisher Scientific
  10.11.1 Thermo Fisher Scientific Company Details
  10.11.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  10.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
  10.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2015-2020)
  10.11.5 Thermo Fisher Scientific Recent Development
13.12 Shanghai RAAS
  10.12.1 Shanghai RAAS Company Details
  10.12.2 Shanghai RAAS Business Overview and Its Total Revenue
  10.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
  10.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2015-2020)
  10.12.5 Shanghai RAAS Recent Development
13.13 China Biologic Products
  10.13.1 China Biologic Products Company Details
  10.13.2 China Biologic Products Business Overview and Its Total Revenue
  10.13.3 China Biologic Products Critical Care Therapeutics Introduction
  10.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2015-2020)
  10.13.5 China Biologic Products Recent Development
13.14 Cosmo Pharmaceuticals
  10.14.1 Cosmo Pharmaceuticals Company Details
  10.14.2 Cosmo Pharmaceuticals Business Overview and Its Total Revenue
  10.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
  10.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2015-2020)
  10.14.5 Cosmo Pharmaceuticals Recent Development
13.15 King Pharmaceuticals
  10.15.1 King Pharmaceuticals Company Details
  10.15.2 King Pharmaceuticals Business Overview and Its Total Revenue
  10.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
  10.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2015-2020)
  10.15.5 King Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Critical Care Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Critical Care Therapeutics Revenue
Table 3. Ranking of Global Top Critical Care Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Critical Care Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Albumin
Table 6. Key Players of Prothrombin Complex Concentrates
Table 7. Key Players of Antithrombin Concentrates
Table 8. Key Players of Factor XIII Concentrates
Table 9. Key Players of Fibrinogen Concentrates
Table 10. COVID-19 Impact Global Market: (Four Critical Care Therapeutics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Critical Care Therapeutics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Critical Care Therapeutics Players to Combat Covid-19 Impact
Table 15. Global Critical Care Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Critical Care Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Critical Care Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Critical Care Therapeutics Market Share by Regions (2015-2020)
Table 19. Global Critical Care Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Critical Care Therapeutics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Critical Care Therapeutics Market Growth Strategy
Table 25. Main Points Interviewed from Key Critical Care Therapeutics Players
Table 26. Global Critical Care Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Critical Care Therapeutics Market Share by Players (2015-2020)
Table 28. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Therapeutics as of 2019)
Table 29. Global Critical Care Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Critical Care Therapeutics Product Solution and Service
Table 32. Date of Enter into Critical Care Therapeutics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. Global Critical Care Therapeutics Market Size Share by Type (2015-2020)
Table 36. Global Critical Care Therapeutics Revenue Market Share by Type (2021-2026)
Table 37. Global Critical Care Therapeutics Market Size Share by Application (2015-2020)
Table 38. Global Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. Global Critical Care Therapeutics Market Size Share by Application (2021-2026)
Table 40. North America Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 42. North America Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. North America Critical Care Therapeutics Market Share by Type (2015-2020)
Table 44. North America Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. North America Critical Care Therapeutics Market Share by Application (2015-2020)
Table 46. Europe Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 48. Europe Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Critical Care Therapeutics Market Share by Type (2015-2020)
Table 50. Europe Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Critical Care Therapeutics Market Share by Application (2015-2020)
Table 52. China Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 54. China Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. China Critical Care Therapeutics Market Share by Type (2015-2020)
Table 56. China Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. China Critical Care Therapeutics Market Share by Application (2015-2020)
Table 58. Japan Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 60. Japan Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Critical Care Therapeutics Market Share by Type (2015-2020)
Table 62. Japan Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Critical Care Therapeutics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 66. Southeast Asia Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Critical Care Therapeutics Market Share by Type (2015-2020)
Table 68. Southeast Asia Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Critical Care Therapeutics Market Share by Application (2015-2020)
Table 70. India Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 72. India Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. India Critical Care Therapeutics Market Share by Type (2015-2020)
Table 74. India Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. India Critical Care Therapeutics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Critical Care Therapeutics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Critical Care Therapeutics Market Share (2019-2020)
Table 78. Central & South America Critical Care Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Critical Care Therapeutics Market Share by Type (2015-2020)
Table 80. Central & South America Critical Care Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Critical Care Therapeutics Market Share by Application (2015-2020)
Table 82. CSL Behring Company Details
Table 83. CSL Behring Business Overview
Table 84. CSL Behring Product
Table 85. CSL Behring Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 86. CSL Behring Recent Development
Table 87. Grifols Company Details
Table 88. Grifols Business Overview
Table 89. Grifols Product
Table 90. Grifols Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 91. Grifols Recent Development
Table 92. Kedrion Biopharma Company Details
Table 93. Kedrion Biopharma Business Overview
Table 94. Kedrion Biopharma Product
Table 95. Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 96. Kedrion Biopharma Recent Development
Table 97. Octapharma Company Details
Table 98. Octapharma Business Overview
Table 99. Octapharma Product
Table 100. Octapharma Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 101. Octapharma Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Product
Table 105. Takeda Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 106. Takeda Recent Development
Table 107. Bayer HealthCare Company Details
Table 108. Bayer HealthCare Business Overview
Table 109. Bayer HealthCare Product
Table 110. Bayer HealthCare Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 111. Bayer HealthCare Recent Development
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Product
Table 115. Merck Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 116. Merck Recent Development
Table 117. Mitsubishi Tanabe Pharma Business Overview
Table 118. Mitsubishi Tanabe Pharma Product
Table 119. Mitsubishi Tanabe Pharma Company Details
Table 120. Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 121. Mitsubishi Tanabe Pharma Recent Development
Table 122. REVO Biologics Company Details
Table 123. REVO Biologics Business Overview
Table 124. REVO Biologics Product
Table 125. REVO Biologics Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 126. REVO Biologics Recent Development
Table 127. Rockwell Medical Company Details
Table 128. Rockwell Medical Business Overview
Table 129. Rockwell Medical Product
Table 130. Rockwell Medical Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 131. Rockwell Medical Recent Development
Table 132. Thermo Fisher Scientific Company Details
Table 133. Thermo Fisher Scientific Business Overview
Table 134. Thermo Fisher Scientific Product
Table 135. Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 136. Thermo Fisher Scientific Recent Development
Table 137. Shanghai RAAS Company Details
Table 138. Shanghai RAAS Business Overview
Table 139. Shanghai RAAS Product
Table 140. Shanghai RAAS Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 141. Shanghai RAAS Recent Development
Table 142. China Biologic Products Company Details
Table 143. China Biologic Products Business Overview
Table 144. China Biologic Products Product
Table 145. China Biologic Products Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 146. China Biologic Products Recent Development
Table 147. Cosmo Pharmaceuticals Company Details
Table 148. Cosmo Pharmaceuticals Business Overview
Table 149. Cosmo Pharmaceuticals Product
Table 150. Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 151. Cosmo Pharmaceuticals Recent Development
Table 152. King Pharmaceuticals Company Details
Table 153. King Pharmaceuticals Business Overview
Table 154. King Pharmaceuticals Product
Table 155. King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2015-2020) (Million US$)
Table 156. King Pharmaceuticals Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Critical Care Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Albumin Features
Figure 3. Prothrombin Complex Concentrates Features
Figure 4. Antithrombin Concentrates Features
Figure 5. Factor XIII Concentrates Features
Figure 6. Fibrinogen Concentrates Features
Figure 7. Global Critical Care Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Pulmonary Embolism (PE) Case Studies
Figure 9. Acute Coronary Syndrome Case Studies
Figure 10. Atrial Fibrillation Case Studies
Figure 11. Other Case Studies
Figure 12. Critical Care Therapeutics Report Years Considered
Figure 13. Global Critical Care Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Critical Care Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Critical Care Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Critical Care Therapeutics Market Share by Players in 2019
Figure 18. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Critical Care Therapeutics Revenue in 2019
Figure 20. North America Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Critical Care Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CSL Behring Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 29. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Grifols Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 31. Kedrion Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Kedrion Biopharma Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 33. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Octapharma Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 35. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Takeda Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 37. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer HealthCare Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 41. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Mitsubishi Tanabe Pharma Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 43. REVO Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. REVO Biologics Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 45. Rockwell Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Rockwell Medical Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 49. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Shanghai RAAS Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 51. China Biologic Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. China Biologic Products Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 53. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cosmo Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 55. King Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. King Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed